MDMA THERAPY NETHERLANDS

The conditions under which we can continue to supervise MDMA therapy after the ban on analogues as of July 1, 2025, have been carefully aligned with the new legislation and are fully focused on safety, legality, and transparency. MDMA sessions will therefore remain possible, provided the following conditions are met:

1. Own responsibility for the product
You are only permitted to participate in an MDMA session if you bring the drug yourself. This may not exceed 500 mg per person—a quantity considered by the Public Prosecution Service to be a "small amount for personal use." As a participant, you are solely responsible for purchasing, possessing, and using the drug.

2. No provision or delivery by us
We do not provide or sell MDMA or MDMA analogs. Our role is purely supportive. We create a safe and professional environment where you can participate in a supervised session with your own substance.

3. The product must be tested beforehand
You are required to have any medication you bring tested beforehand at a certified testing center, such as the Trimbos Institute's testing service. Only medications whose content and purity have been confirmed can be accepted during our sessions. This increases safety and prevents unwanted risks.

4. Use on own initiative and written confirmation
Before the session, you explicitly and in writing agree that the use of the resource is your own initiative and that the resource is exclusively for you. This agreement ensures that our guidance remains strictly within legal frameworks and that no misunderstandings arise regarding responsibility.

5. Mandatory intake and screening for contraindications
Before we schedule an MDMA session, you must undergo a screening. We do this through this form.